-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FUpE0xwL0QysPZy7oC2eBmxDv+47n+e8wB0jshYO5U9F7GpCUjD8kuZJcwZbl8rT 77V67t8Qb0YLyrgkHO0Ydw== 0001317757-10-000019.txt : 20100609 0001317757-10-000019.hdr.sgml : 20100609 20100609165003 ACCESSION NUMBER: 0001317757-10-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100608 FILED AS OF DATE: 20100609 DATE AS OF CHANGE: 20100609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zayas Ricardo CENTRAL INDEX KEY: 0001465314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 10887645 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-06-08 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001465314 Zayas Ricardo 100 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 SVP, Operations Common Stock 2010-06-08 4 C 0 2500 A 12087 D Common Stock 2010-06-08 4 S 0 300 32.46 D 11787 D Common Stock 2010-06-08 4 S 0 100 32.462 D 11687 D Common Stock 2010-06-08 4 S 0 400 32.47 D 11287 D Common Stock 2010-06-09 4 S 0 295 32.46 D 10992 D Common Stock 2010-06-09 4 S 0 100 32.45 D 10892 D Restricted Stock Unit 2010-06-08 4 C 0 2500 0 A Common Stock 2500 2500 D Not applicable. Each restricted stock unit represents a contingent right to receive one unit of the Issuer's common stock. Grant of restricted stock unit pursuant to AMAG Pharmaceuticals, Inc.'s Amended and Restated 2007 Equity Incentive Plan. The grant is exercisable in four equal installments. The first installment vested on June 8, 2010, the first anniversary of the grant. The remaining installments will vest on June 8, 2011, June 8, 2012, June 8, 2013, respectively. Joseph L. Farmer, attorney-in-fact 2010-06-09 -----END PRIVACY-ENHANCED MESSAGE-----